BMJ Open Respiratory Research

Papers
(The median citation count of BMJ Open Respiratory Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Classification of aerosol-generating procedures: a rapid systematic review123
Sleep apnoea is a risk factor for severe COVID-1988
SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’76
Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in ‘long COVID’ patients with persistent dyspnoea57
Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service56
Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA53
Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals51
Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure51
Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area51
Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence50
Rationale for azithromycin in COVID-19: an overview of existing evidence46
Last-resort strategies during mask shortages: optimal design features of cloth masks and decontamination of disposable masks during the COVID-19 pandemic43
Patient symptoms and experience following COVID-19: results from a UK-wide survey43
CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation43
Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital42
ARTP statement on pulmonary function testing 202041
Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre high-dependency unit experience38
Specialty COPD care during COVID-19: patient and clinician perspectives on remote delivery36
Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda34
Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study33
Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey33
ARTP statement on cardiopulmonary exercise testing 202131
Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells30
COVID-19 recovery: benefits of multidisciplinary respiratory rehabilitation29
Efficacy of convalescent plasma for treatment of COVID-19 in Uganda28
Early conscious prone positioning in patients with COVID-19 receiving continuous positive airway pressure: a retrospective analysis27
Impact of corticosteroids in hospitalised COVID-19 patients26
Respiratory tract infections (RTIs) in primary care: narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients who present with symptoms of RTI26
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)26
Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort26
Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease26
Moving singing for lung health online in response to COVID-19: experience from a randomised controlled trial26
Novel electronic adherence monitoring devices in children with asthma: a mixed-methods study25
Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis24
Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: systematic review and meta-analysis24
Working accuracy of pulse oximetry in COVID-19 patients stepping down from intensive care: a clinical evaluation23
Disease burden and quality of life of patients with chronic cough in Japan: a population-based cross-sectional survey23
Underlying contributing conditions to breathlessness among middle-aged individuals in the general population: a cross-sectional study23
Vimentin as a target for the treatment of COVID-1923
How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey22
Real-world retrospective observational study exploring the effectiveness and safety of antifibrotics in idiopathic pulmonary fibrosis22
Experiences of nurses caring for respiratory patients during the first wave of the COVID-19 pandemic: an online survey study22
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease21
Management of tracheostomies in the intensive care unit: a scoping review21
Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-1921
Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnoea in patients with cardiovascular risk factors: a systematic review and meta-analysis21
Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study21
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung dise21
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response21
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study20
Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis19
Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank19
BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD18
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review17
Sudden death in individuals with obstructive sleep apnoea: a systematic review and meta-analysis17
Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries17
Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test17
Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design16
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis15
British Thoracic Society Training Standards for Thoracic Ultrasound (TUS)15
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry15
Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases15
What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?15
Association of smoking status with outcomes in hospitalised patients with COVID-1915
Economic burden of asthma in Singapore14
Monocyte and neutrophil levels are potentially linked to progression to IPF for patients with indeterminate UIP CT pattern14
CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial14
Ambient air pollution and risk of respiratory infection among adults: evidence from the multiethnic study of atherosclerosis (MESA)14
129Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome14
Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies14
Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey14
Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study14
Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial13
Ambient air pollution, lung function and COPD: cross-sectional analysis from the WHO Study of AGEing and adult health wave 113
Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations—a cross-sectional study13
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK13
Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis13
The physiology of singing and implications for ‘Singing for Lung Health’ as a therapy for individuals with chronic obstructive pulmonary disease13
Lung ultrasound volume sweep imaging for respiratory illness: a new horizon in expanding imaging access13
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis13
Immediate smoking cessation support versus usual care in smokers attending a targeted lung health check: the QuLIT trial12
Utility of radial endobronchial ultrasonography combined with transbronchial lung cryobiopsy in patients with diffuse parenchymal lung diseases: a multicentre prospective study12
Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Aus12
Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts12
Dance for people with chronic breathlessness: a transdisciplinary approach to intervention development12
Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review12
Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies11
Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England11
Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation11
Frailty assessment for COVID-19 follow-up: a prospective cohort study11
Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID: the InsCOVID trial11
Prompt recognition of infectious pulmonary tuberculosis is critical to achieving elimination goals: a retrospective cohort study11
Cardiopulmonary function in adolescent patients with pectus excavatum or carinatum11
Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study11
Readily accessible CT scoring method to quantify fibrosis in IPF11
Endotypes identified by cluster analysis in asthmatics and non-asthmatics and their clinical characteristics at follow-up: the case-control EGEA study11
Fine crackles on chest auscultation in the early diagnosis of idiopathic pulmonary fibrosis: a prospective cohort study11
Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia11
Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience10
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol10
Performance of popular pulse oximeters compared with simultaneous arterial oxygen saturation or clinical-grade pulse oximetry: a cross-sectional validation study in intensive care patients10
Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia10
Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter10
Characterisation of ICU sleep by a commercially available activity tracker and its agreement with patient-perceived sleep quality10
Venous thromboembolism in patients with COVID-19 and correlation with D-dimers: a single-centre experience10
ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF10
Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study10
Exploratory cost-effectiveness model of electromagnetic navigation bronchoscopy (ENB) compared with CT-guided biopsy (TTNA) for diagnosis of malignant indeterminate peripheral pulmonary nodules10
Effect of a home-based inspiratory muscular training programme on functional capacity in patients with chronic COVID-19 after a hospital discharge: protocol for a randomised control trial (InsCOVID tr9
Diagnostic and clinical values of non-cardiac ultrasound in COPD: A systematic review9
COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation9
Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis9
Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians9
Lung transplant after 6 months on ECMO support for SARS-CoV-2-induced ARDS complicated by severe antibody-mediated rejection9
Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates9
Early experiences of the Your COVID Recovery®digital programme for individuals with long COVID9
Asthma, atopy and lung function in young adults after hospitalisation for bronchiolitis in infancy: impact of virus and sex9
Web-based survey to evaluate the prevalence of chronic and subacute cough and patient characteristics in Japan9
Deoxynucleoside therapy for respiratory involvement in adult patients with thymidine kinase 2-deficient myopathy9
Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study9
Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysis8
Reslizumab as add-on therapy in patients with refractory asthma8
Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion8
Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy8
‘It’s not one size fits all’: a qualitative study of patients’ and healthcare professionals’ views of self-management for bronchiectasis8
Comparison of prognostic scores for inpatients with COVID-19: a retrospective monocentric cohort study8
Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active8
Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 20218
Development in PaCO2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula—post-hoc analysis from a randomised controlled8
Relationship of Pneumocystis antibody responses to paediatric asthma severity8
Physiological tests of small airways function in diagnosing asthma: a systematic review8
Implementation of prognostic machine learning algorithms in paediatric chronic respiratory conditions: a scoping review8
Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial8
Chest radiograph-based artificial intelligence predictive model for mortality in community-acquired pneumonia8
Physiological demands of singing for lung health compared with treadmill walking8
Inspiratory crackles—early and late—revisited: identifying COPD by crackle characteristics7
Changes in central venous to arterial carbon dioxide gap (PCO2 gap) in response to acute changes in ventilation7
Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database7
Improving the early identification of COVID-19 pneumonia: a narrative review7
Use of peripheral neutrophil to lymphocyte ratio and peripheral monocyte levels to predict survival in fibrotic hypersensitivity pneumonitis (fHP): a multicentre retrospective cohort study7
Minimal clinically important difference for chest discomfort in patients undergoing pleural interventions7
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases7
Trends in hospital admissions and mortality rates for asthma in Ecuador: a joinpoint regression analysis of data from 2000 to 20187
Effectiveness, usability and acceptability of a smart inhaler programme in patients with asthma: protocol of the multicentre, pragmatic, open-label, cluster randomised controlled ACCEPTANCE trial7
Patients’ and their caregivers’ experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study7
Potential for integrating yoga within pulmonary rehabilitation and recommendations of reporting framework7
Correlation of respiratory oscillometry with CT image analysis in a prospective cohort of idiopathic pulmonary fibrosis7
Remote-Management of COPD: Evaluating the Implementation of Digital Innovation to Enable Routine Care (RECEIVER): the protocol for a feasibility and service adoption observational cohort study7
Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed 7
Persisting breathlessness and activities reduced or ceased: a population study in older men7
Health economic analysis for the ‘CURE Project’ pilot: a hospital-based tobacco dependency treatment service in Greater Manchester6
Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases6
Assistive technologies for home NIV in patients with COPD: feasibility and positive experience with remote-monitoring and volume-assured auto-EPAP NIV mode6
Stability in eosinophil categorisation during subsequent severe exacerbations of COPD6
Prevalence and risk factors for COPD in subjects with preserved ratio impaired spirometry6
Acute hypoxaemic respiratory failure in a low-income country: a prospective observational study of hospital prevalence and mortality6
Automatic versus manual oxygen titration using a novel nasal high-flow device in medical inpatients with an acute illness: a randomised controlled trial6
Novel non-invasive particles in exhaled air method to explore the lining fluid of small airways—a European population-based cohort study6
Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD6
Symptomatic, biochemical and radiographic recovery in patients with COVID-196
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance6
Low utilisation of bronchoscopy to assess COVID-19 respiratory infection: a multicenter experience6
Rat model of smoke inhalation-induced acute lung injury6
Large scale clinical trials: lessons from the COVID-19 pandemic6
Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population6
Is there an association between subjective sleep quality and daily delirium occurrence in critically ill adults? A post hoc analysis of a randomised controlled trial6
Clinical features of COVID-19 patients with rebound phenomenon after corticosteroid therapy6
Early respiratory diagnosis: benefits of enhanced lung function assessment5
Objective measurement of lung volume recruitment therapy: laboratory and clinical validation5
Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Data5
COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients5
Impact of dietary nitrate supplementation on exercise capacity and cardiovascular parameters in chronic respiratory disease: a systematic review and meta-analysis5
Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics5
Non-invasive testing for liver pathology in alpha-1 antitrypsin deficiency5
Estimating population-based incidence of community-acquired pneumonia and acute otitis media in children and adults in Ontario and British Columbia using health administrative data, 2005–2018: a Canad5
Physical and affective components of dyspnoea are improved by pulmonary rehabilitation in COPD5
Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study5
Coil embolisation for massive haemoptysis in cystic fibrosis5
Extracorporeal CO2 removal in acute exacerbation of COPD unresponsive to non-invasive ventilation5
Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study5
Association of body mass index with morbidity in patients hospitalised with COVID-195
Typical within and between person variability in non-invasive ventilator derived variables among clinically stable, long-term users5
COVID-19 admission risk tools should include multiethnic age structures, multimorbidity and deprivation metrics for air pollution, household overcrowding, housing quality and adult skills5
Association of sleep apnoea risk and aortic enlargement in Marfan syndrome5
Treatment patterns and frequency of key outcomes in acute severe asthma in children: a Paediatric Research in Emergency Departments International Collaborative (PREDICT) multicentre cohort study5
Examining the possible causal relationship between lung function, COPD and Alzheimer’s disease: a Mendelian randomisation study5
Small airway function measured using forced expiratory flow between 25% and 75% of vital capacity and its relationship to airflow limitation in symptomatic ever-smokers: a cross-sectional study5
Lung cancer in recipients after lung transplant: single-centre experience and literature review5
Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity5
The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD5
Undiagnosed and ‘overdiagnosed’ COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis5
Influence of asthma and obesity on respiratory symptoms, work ability and lung function: findings from a cross-sectional Norwegian population study5
Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study5
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM s4
CPAP delivered outside critical care during the second wave of COVID-19: outcomes from a UK respiratory surge unit4
Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study4
Diagnostic value and safety of thoracoscopic pleural biopsies in pleural exudative effusions of unknown origin, including follow-up4
Registry-based cohort study of alpha-1 antitrypsin deficiency prevalence, incidence and mortality in Denmark 2000–20184
Exploration of therapists’ views of practice within critical care4
Reflexive thematic analysis exploring stakeholder experiences of virtual pulmonary rehabilitation (VIPAR)4
Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire4
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease4
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?4
Disinfection of Pseudomonas aeruginosa from N95 respirators with ozone: a pilot study4
Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic4
Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis andPseudomonas aeruginosa4
Immediate effects of systemic administration of normal and high O2-affinity haemoglobin vesicles as a transfusion alternative in a rat pneumonectomy model4
Novel method to select meaningful outcomes for evaluation in clinical trials4
The ‘ABC’ of respiratory disorders among adult Indigenous people: asthma, bronchiectasis and COPD among Aboriginal Australians – a systematic review4
In vitro evaluation of disposable transport ventilators with combination aerosol therapy4
Defining hypoxaemia from pulse oximeter measurements of oxygen saturation in well children at low altitude in Bangladesh: an observational study4
Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study4
New method to measure interbreath intervals in infants for the assessment of apnoea and respiration4
Highlighting the importance of healthy sleep patterns in the risk of adult asthma under the combined effects of genetic susceptibility: a large-scale prospective cohort study of 455 405 participants4
Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation4
Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapies4
Childhood ‘bronchitis’ and respiratory outcomes in middle-age: a prospective cohort study from age 7 to 53 years4
Prevalence and burden of COPD misclassification in the Canadian Longitudinal Study on Aging (CLSA)4
Ten-year prediction model for post-bronchodilator airflow obstruction and early detection of COPD: development and validation in two middle-aged population-based cohorts4
Comparison of influenza and COVID-19 hospitalisations in British Columbia, Canada: a population-based study4
BTS clinical statement for the diagnosis and management of ocular tuberculosis4
Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resecta4
High prevalence of exercise-induced stridor during Parkrun: a cross-sectional field-based evaluation4
Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients4
Comparison of the efficacy of novel two covering methods for spontaneous pneumothorax: a multi-institutional study4
Association of respiratory symptoms with body mass index and occupational exposure comparing sexes and subjects with and without asthma: follow-up of a Norwegian population study (the Telemark study)4
Predictors of postoperative acute exacerbation of interstitial lung disease: a case–control study4
Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians4
Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer3
Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss3
Enhanced airway sensory nerve reactivity in non-eosinophilic asthma3
Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study3
Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthma3
Exploring the impact of elexacaftor-tezacaftor-ivacaftor treatment on opinions regarding airway clearance techniques and nebulisers: TEMPO a qualitative study in children with cystic fibrosis, their f3
Performance monitoring of EBUS for the staging and diagnosis of lung cancer: auditing the Greater Manchester EBUS service against new national standards3
Integrating patients with chronic respiratory disease and heart failure into a combined breathlessness rehabilitation programme: a service redesign and pilot evaluation3
Sleep apnoea and hypoventilation in patients with five major types of muscular dystrophy3
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial3
Two chair test: a substitute of 6 min walk test appear cardiopulmonary reserve specific3
Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension3
Lower geriatric nutritional risk index is associated with a higher risk of all-cause mortality in patients with chronic obstructive pulmonary disease: a cohort study from the National Health and Nutri3
Physiological changes related to 10 weeks of singing for lung health in patients with COPD3
Smoking and socioeconomic factors linked to acute exacerbations of COPD: analysis from an Asthma + Lung UK survey3
Serum KL-6 levels predict clinical outcomes and are associated withMUC1polymorphism in Japanese patients with COVID-193
Trending peripheral venous PCO2in patients with respiratory failure using mathematically arterialised venous blood gas samples3
Developing an intrasalivary gland botox service for patients receiving long-term non-invasive ventilation at home: a single-centre experience3
Rapidly and slowly progressive neuromuscular disease: differences in pulmonary function, respiratory tract infections and response to lung volume recruitment therapy (LVR)3
Ultrasonographic assessment of diaphragmatic contraction and relaxation properties: correlations of diaphragmatic displacement with oesophageal and transdiaphragmatic pressure3
Specialist pneumonia intervention nurse service improves pneumonia care and outcome3
Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant3
0.042949914932251